These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9867333)

  • 1. The effect of a new tear substitute containing glycerol and hyaluronate on keratoconjunctivitis sicca.
    Solomon A; Merin S
    J Ocul Pharmacol Ther; 1998 Dec; 14(6):497-504. PubMed ID: 9867333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations. A comparison in patients with keratoconjunctivitis sicca.
    Nelson JD; Farris RL
    Arch Ophthalmol; 1988 Apr; 106(4):484-7. PubMed ID: 2451494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of the ocular surface using hypotonic 0.4% hyaluronic acid drops in keratoconjunctivitis sicca.
    Iester M; Orsoni GJ; Gamba G; Taffara M; Mangiafico P; Giuffrida S; Rolando M
    Eye (Lond); 2000 Dec; 14(Pt 6):892-8. PubMed ID: 11584850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low spatial-contrast sensitivity in dry eyes.
    Rolando M; Iester M; Macrí A; Calabria G
    Cornea; 1998 Jul; 17(4):376-9. PubMed ID: 9676908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients.
    Lee HK; Ryu IH; Seo KY; Hong S; Kim HC; Kim EK
    Ophthalmology; 2006 Feb; 113(2):198-205. PubMed ID: 16360211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium hyaluronate in the treatment of keratoconjunctivitis sicca. A double masked clinical trial.
    Sand BB; Marner K; Norn MS
    Acta Ophthalmol (Copenh); 1989 Apr; 67(2):181-3. PubMed ID: 2658462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
    Hwang HS; Sung YM; Lee WS; Kim EC
    Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical fibronectin in the treatment of keratoconjunctivitis sicca. Chiron Keratoconjunctivitis Sicca Study Group.
    Nelson JD; Gordon JF
    Am J Ophthalmol; 1992 Oct; 114(4):441-7. PubMed ID: 1415455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rose bengal staining as an assessment of ocular surface damage and recovery in dry eye disease-a review.
    Doughty MJ
    Cont Lens Anterior Eye; 2013 Dec; 36(6):272-80. PubMed ID: 23928365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a physiological tear substitute in patients with keratoconjunctivitis sicca.
    Nelson JD; Drake MM; Brewer JT; Tuley M
    Adv Exp Med Biol; 1994; 350():453-7. PubMed ID: 8030518
    [No Abstract]   [Full Text] [Related]  

  • 11. Biomicroscopy of the tear film: aqueous and lipid tear substitutes in the normal and abnormal eye.
    Carrington S; Bedford PG; Guillon JP; Carlile JL; Woodward EG
    Vet Rec; 1988 Sep; 123(13):329-35. PubMed ID: 3195015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Periocular Fatty Acids and 0.15% Hyaluronate Eye Drops Application on Keratoconjunctivitis Sicca in Dogs: An Exploratory Study.
    Amalfitano C; Pasolini MP; Nieddu A; Della Valle G; Fiorentin PG; Lamagna F; Lamagna B
    Top Companion Anim Med; 2019 Jun; 35():18-25. PubMed ID: 31122683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical application of hyaluronic acid and chondroitin sulfate in the treatment of dry eyes.
    Limberg MB; McCaa C; Kissling GE; Kaufman HE
    Am J Ophthalmol; 1987 Feb; 103(2):194-7. PubMed ID: 3101502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and differential diagnosis of keratoconjunctivitis sicca associated with tear gland degeneration.
    Van Bijsterveld OP
    Clin Exp Rheumatol; 1990; 8 Suppl 5():3-6. PubMed ID: 2245523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of keratoconjunctivitis sicca with Lacrisert.
    Prause JU
    Scand J Rheumatol Suppl; 1986; 61():261-3. PubMed ID: 3296154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precorneal residence times of sodium hyaluronate solutions studied by quantitative gamma scintigraphy.
    Snibson GR; Greaves JL; Soper ND; Prydal JI; Wilson CG; Bron AJ
    Eye (Lond); 1990; 4 ( Pt 4)():594-602. PubMed ID: 2226990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.
    Kono I; Matsumoto Y; Kono K; Ishibashi Y; Narushima K; Kabashima T; Yamane K; Sakurai T; Kashiwagi H
    J Rheumatol; 1985 Jun; 12(3):487-9. PubMed ID: 4045849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model.
    Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS
    Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca.
    Gilbard JP; Farris RL
    Arch Ophthalmol; 1979 Sep; 97(9):1642-6. PubMed ID: 475632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical cyclosporine A 0.05% in the treatment of keratoconjunctivitis sicca].
    Schrell C; Cursiefen C; Kruse F; Jacobi C
    Klin Monbl Augenheilkd; 2012 May; 229(5):548-53. PubMed ID: 22189827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.